BGI Partners with PentaBase to Develop PCR-Based Dx Kits | GenomeWeb
NEW YORK (GenomeWeb News) – The Beijing Genome Institute and the Danish diagnostic developer PentaBase have agreed to co-develop disease detection kits using genetic biomarkers, PentaBase said today.
 
The agreement expands an ongoing collaboration with SD Genomics, which serves as BGI’s contact point in Denmark, that is focused on developing and launching real-time PCR-based diagnostics kits.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.